15. Haemostasis and thrombosis Flashcards

1
Q

What are the 3 stages of coagulation?

A
  • Initiation
  • Amplification
  • Propagation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What happens in the initiation stage of coagulation?

A

Small-scale thrombin production
• Tissue factor bearing cells activate factors 10 and 5 => forms prothrombinase complex
• Prothrombinase complex activates factor 2 (prothrombin) creating factor 2a (thrombin)
• Antithrombin (AT-III) inactivates factors 2a and 10a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
How do the following work as anticoagulants in the initiation stage:
• Dabigatran (oral)
• Rivaroxaban (oral)
• Heparin (IV, SC)
• Low-molecular weight heparins (SC)
• Warfarin (oral)
A
  • Dabigatran - factor 2a inhibitor (GI bleeding so not commonly used)
  • Rivaroxaban - factor 10a inhibitor
  • Heparin - activates AT-III
  • Low-molecular weight heparins - activates AT-III, also thought to directly affect 10a
  • Warfarin - vitamin K antagonist (required for the generations of factors 2, 7, 9, 10)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What does a positive D-dimer test suggest and what do you following this diagnosis?

A
  • DVT
  • Interim treatment with parenteral anticoagulant
  • Dalteparin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What do you do following an ultrasound scan confirming a DVT/pulmonary embolism?

A
  • Maintenance treatment with oral anticoagulant

* Rivaroxaban/warfarin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What treatment do you use following the confirmation of a pulmonary embolism with a CTPA (computed tomographic pulmonary angiography)?

A
  • Dalteparin

* Heparin if more serious

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the risk factors for DVT/pulmonary embolism (Virchow’s triad)?

A
  • Rate of blood flow - blood flow is slow, no replenishment of anticoagulating factors
  • Consistency of blood - natural imbalance between procoagulation and anticoagulation factors
  • Blood vessel wall integrity - damaged endothelia, blood exposed to procoagulation factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What happens in a non-ST elevated myocardial infarction (NSTEMI) and how is it treated?

A
  • White thrombus (contains foam cells)
  • Partially occluded coronary artery => ischaemia
  • Antiplatelets
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Where/when does a red thrombus form?

A

DVT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What happens in a ST elevated MI (STEMI)?

A
  • White thrombus
  • Fully occluded coronary artery
  • Lack of oxygen
  • Cell death and necrosis
  • Antiplatelets and thrombolytics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What leads to a STEMI?

A
  • Damage to endothelium
  • Atheroma formation
  • Platelet aggregation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the risk factors for a STEMI mainly associated with?

A

Diet - high fat/high LDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Is the thrombosis in both an artery and vein subendothelial?

A

No, just artery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What happens in the amplification stage of coagulation?

A
  • Thrombin binds to protease -activated receptors (PAR) on the platelet surface
  • PAR activation - rise in intracellular Ca2+
  • Exocytosis of ADP from dense granules
  • ADP activates P2Y12 receptors - platelet activation/aggregation
  • PAR/P2Y12 activation liberates arachidonic acid (AA)
  • COX generates thromboxane A2 from AA
  • This causes the expression of GPIIb/IIIa integrin receptor on platelet surface
  • Activated platelets change shape, become sticky and attach other platelets
  • Platelets themselves begin converting more thrombinase into thrombin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How do the following work as anticoagulants in the amplification stage:
• Clopidogrel (oral)
• Aspirin (oral)
• Abciximab (IV, SC)

A
  • Clopidogrel - ADP (P2Y12) receptor antagonist
  • Aspirin - irreversible COX-1 inhibitor, prevents TXA2 formation, lack of GPIIb expression
  • Abciximab - monoclonal antibody inhibits GPIIb/IIIa receptor (limited, specialist use)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How does a high dose change the effectiveness of aspirin?

A

It doesn’t. Just gives you more side-effects.

17
Q

Which medication is used in ‘thrombolytic therapy’?

A

Alteplase - rt-PA (recombinant tissue type plasminogen activator) (IV)

18
Q

How does a clot form in a stroke?

A
  • Clot forms in one of the atria of the heart (increased risk with AF)
  • Clot embolises
  • Blocks one of the cerebral arteries
  • Necrosis
19
Q

What happens in the propagation stage of coagulation?

A
  • Activated platelets => large-scale thrombin production
  • Thrombin binds to fibrinogen, converting it to fibrin
  • Fibrin strands stabilise the clot
20
Q

Do anticoagulants or antiplatelets remove pre-formed clots?

A

no

21
Q

How do thrombolytics work?

A
  • Convert plasminogen => plasmin
  • Plasmin is a protease that degrades fibrin
  • Once the fibrin has broken down, the clot will dissolve
22
Q

Why are thrombolytics not used to treat DVT and PE?

A
  • Cause excessive bleeding
  • Increase the livelihood of patients dying

(used in an emergency setting for ischaemic stroke and possibly STEMI)

23
Q

What type of medication is used in the propagation stage of coagulation?

A

Thrombolytics